Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017 Nov. 92 (11):1243-1259. [QxMD MEDLINE Link]. [Full Text].
Spry CJF, ed. Eosinophils: A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford, UK: Oxford University Press; 1988.
Gotlib J. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol. 2005. 114(1):7-25. [QxMD MEDLINE Link].
Prieto R, Richter JE. Eosinophilic esophagitis in adults: an update on medical management. Curr Gastroenterol Rep. 2013 Jun. 15(6):324. [QxMD MEDLINE Link].
Feldman RE, Lam AC, Sadow PM, Bleier BS. P-glycoprotein is a marker of tissue eosinophilia and radiographic inflammation in chronic rhinosinusitis without nasal polyps. Int Forum Allergy Rhinol. 2013 May 15. [QxMD MEDLINE Link].
Kasamatsu Y, Kida T, Shigeru M, Tagashira T, Murai N, Takai E, et al. Clinically suspected acute myopericarditis with cardiac tamponade associated with peripheral blood eosinophilia presenting in early pregnancy: a case report. J Med Case Rep. 2013 May 13. 7(1):129. [QxMD MEDLINE Link]. [Full Text].
Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006 Jun. 133(5):468-92. [QxMD MEDLINE Link].
Criado PR, Criado RF, Avancini Jde M, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012 May-Jun. 87(3):435-49. [QxMD MEDLINE Link].
Watanabe H. Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. J Immunol Res. 2018. 2018:5163129. [QxMD MEDLINE Link]. [Full Text].
Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994 May 15. 83(10):2759-79. [QxMD MEDLINE Link]. [Full Text].
Bain BJ. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis. Am J Hematol. 2004 Sep. 77(1):82-5. [QxMD MEDLINE Link]. [Full Text].
Gotlib J, Cools J, Malone JM 3rd, et al. The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood. 2004 Apr 15. 103(8):2879-91. [QxMD MEDLINE Link]. [Full Text].
Tefferi A. Modern diagnosis and treatment of primary eosinophilia. Acta Haematol. 2005. 114(1):52-60. [QxMD MEDLINE Link].
Fletcher S, Bain B. Eosinophilic leukaemia. Br Med Bull. 2007. 81-2:115-27. [QxMD MEDLINE Link]. [Full Text].
Arefi M, Robledo C, Peñarrubia MJ, de Coca AG, Cordero M, Hernández-Rivas JM, et al. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia. Eur J Haematol. 2014 Nov. 93(5):422-8. [QxMD MEDLINE Link].
Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019 Oct. 94 (10):1149-1167. [QxMD MEDLINE Link]. [Full Text].
Leverone N, Tran S, Barry J, Akuthota P. Diagnoses associated with peripheral blood eosinophilia: A 5-year review. Ann Allergy Asthma Immunol. 2021 Nov. 127 (5):597-598. [QxMD MEDLINE Link]. [Full Text].
Weller PF. Eosinophilia in travelers. Med Clin North Am. 1992 Nov. 76(6):1413-32. [QxMD MEDLINE Link].
Abe Y, Sasaki Y, Yagi M, Mizumoto N, Onozato Y, Umehara M, et al. Endoscopic Diagnosis of Eosinophilic Esophagitis: Basics and Recent Advances. Diagnostics (Basel). 2022 Dec 16. 12 (12):[QxMD MEDLINE Link]. [Full Text].
Di Micco P, Scudiero O, Lombardo B, Lodigiani C. Idiopathic Hypereosinophilia and Venous Thromboembolism: Is There a Pathophysiological or Clinical Link? Description of an Intriguing Clinical Case. J Blood Med. 2020. 11:73-76. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017 Feb. 176 (4):553-572. [QxMD MEDLINE Link]. [Full Text].
Boyer DF. Blood and Bone Marrow Evaluation for Eosinophilia. Arch Pathol Lab Med. 2016 Oct. 140 (10):1060-7. [QxMD MEDLINE Link]. [Full Text].
Soter S, Barta I, Antus B. Predicting Sputum Eosinophilia in Exacerbations of COPD Using Exhaled Nitric Oxide. Inflammation. 2013 May 17. [QxMD MEDLINE Link].
[Guideline] Aceves SS, Alexander JA, Baron TH, Bredenoord AJ, Day L, Dellon ES, et al. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc. 2022 Oct. 96 (4):576-592.e1. [QxMD MEDLINE Link]. [Full Text].
Kirchhof MG, Wong A, Dutz JP. Cyclosporine Treatment of Drug-Induced Hypersensitivity Syndrome. JAMA Dermatol. 2016 Nov 1. 152 (11):1254-1257. [QxMD MEDLINE Link].
Hana CK, Caldera H. Hypereosinophilic Syndrome, Multiorgan Involvement and Response to Imatinib. Cureus. 2020 Jun 7. 12 (6):e8493. [QxMD MEDLINE Link]. [Full Text].
Jain N, Cortes J, Quintas-Cardama A, et al. Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation status. Leuk Res. 2009 Jun. 33(6):837-9. [QxMD MEDLINE Link].
Gotlib J. Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis. Curr Hematol Malig Rep. 2015 Sep 24. 79(5):441-7. [QxMD MEDLINE Link].
Fraticelli P, Kafyeke A, Mattioli M, Martino GP, Murri M, Gabrielli A. Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib. World J Clin Cases. 2016 Oct 16. 4 (10):328-332. [QxMD MEDLINE Link]. [Full Text].
Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med. 1994 Nov. 150(5 Pt 1):1423-38. [QxMD MEDLINE Link].
Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis. 1996 Sep. 174(3):615-8. [QxMD MEDLINE Link].
Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2009 May 19. epub ahead of print. [QxMD MEDLINE Link].
Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009 Mar 5. 360(10):985-93. [QxMD MEDLINE Link].
Nand R, Bryke C, Kroft SH, et al. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors. Leuk Res. 2009 Aug. 33(8):1144-6. [QxMD MEDLINE Link].
Roufosse F, Goldman M, Cogan E. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med. 2006 Apr. 27(2):158-70. [QxMD MEDLINE Link].
Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020 Jul. 146 (1):1-7. [QxMD MEDLINE Link]. [Full Text].
Abe Y, Sasaki Y, Yagi M, Mizumoto N, Onozato Y, Umehara M, et al. Endoscopic Diagnosis of Eosinophilic Esophagitis: Basics and Recent Advances. Diagnostics (Basel). 2022 Dec 16. 12 (12):[QxMD MEDLINE Link]. [Full Text].